Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 540, doi. 10.1111/dom.15341

By:

• Shah, Viral N.;
• Al‐Karadsheh, Amer;
• Barnes, Cathy;
• Mandry, Jose;
• Nakhle, Samer;
• Wernicke‐Panten, Karin;
• Kramer, Daniel;
• Schmider, Wolfgang;
• Pierre, Suzanne;
• Teichert, Lenore;
• Rotthaeuser, Baerbel;
• Mukherjee, Bhaswati;
• Bailey, Timothy S.

Publication type:

Article